Chinese General Practice ›› 2023, Vol. 26 ›› Issue (06): 672-680.DOI: 10.12114/j.issn.1007-9572.2022.0573
Special Issue: 消化系统疾病最新文章合集; 肥胖最新文章合集
• Original Research • Previous Articles Next Articles
Received:
2022-07-26
Revised:
2022-09-12
Published:
2023-02-20
Online:
2022-10-09
Contact:
ZHOU Weihong
About author:
通讯作者:
周卫红
作者简介:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0573
组别 | 例数 | 性别(男/女) | 年龄(岁) | BMI(kg/m2) | BF(kg) | BFR(%) | VFA(cm2) | WC(cm) | WHR |
---|---|---|---|---|---|---|---|---|---|
非肥胖非脂肪肝组 | 129 | 83/46 | 50.4±11.3 | 19.1±1.1a | 10.18±3.84a | 18.74±5.86a | 45.12±19.97a | 74.65±6.21a | 0.85±0.04a |
肥胖MAFLD组 | 129 | 83/46 | 50.3±10.0 | 25.7±0.5a | 20.55±3.05a | 29.19±4.98 | 93.03±22.31a | 88.78±9.47a | 0.93±0.08a |
肥胖非脂肪肝组 | 129 | 83/46 | 51.4±11.1 | 25.3±0.2a | 19.25±3.23a | 27.91±5.43 | 89.00±19.95 | 88.24±4.95a | 0.91±0.04 |
非肥胖MAFLD组 | 129 | 83/46 | 50.0±10.8 | 23.6±1.0 | 18.13±3.58 | 27.54±6.08 | 84.27±22.85 | 84.93±11.47 | 0.91±0.04 |
F(χ2)值 | 0b | 0.411 | 1 860.606 | 232.043 | 91.826 | 135.513 | 77.650 | 62.614 | |
P值 | 1.000 | 0.745 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
组别 | TC(mmol/L) | TG(mmol/L) | HDL-C(mmol/L) | LDL-C(mmol/L) | FPG(mmol/L) | UA(μmol/L) | ALT(U/L) | GGT(U/L) | HbA1c(%) |
非肥胖非脂肪肝组 | 4.36±0.82a | 1.01±0.55a | 1.51±0.33a | 2.41±0.69a | 5.19±1.68 | 324.11±93.29a | 20.46±13.14a | 26.83±42.05a | 5.60±0.75 |
肥胖MAFLD组 | 4.76±0.95 | 2.13±1.47 | 1.15±0.29 | 2.77±0.73 | 6.26±2.13a | 377.13±95.88 | 36.66±22.48 | 49.92±54.22 | 6.15±1.35a |
肥胖非脂肪肝组 | 4.61±0.84 | 1.45±1.06a | 1.23±0.27 | 2.76±0.69 | 5.31±1.55 | 352.25±78.08a | 25.06±17.09a | 30.10±20.91a | 5.72±1.03 |
非肥胖MAFLD组 | 4.78±0.86 | 1.90±1.19 | 1.20±0.29 | 2.83±0.71 | 5.52±1.49 | 383.01±95.80 | 33.04±29.26 | 44.62±39.89 | 5.81±0.88 |
F(χ2)值 | 6.389 | 25.526 | 38.391 | 9.591 | 9.956 | 11.243 | 15.372 | 9.453 | 6.795 |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 1 Demographic information,body fat composition and metabolic indices in non-obese healthy cases,obese cases with MAFLD,obese cases without MAFLD,and non-obese cases with MAFLD
组别 | 例数 | 性别(男/女) | 年龄(岁) | BMI(kg/m2) | BF(kg) | BFR(%) | VFA(cm2) | WC(cm) | WHR |
---|---|---|---|---|---|---|---|---|---|
非肥胖非脂肪肝组 | 129 | 83/46 | 50.4±11.3 | 19.1±1.1a | 10.18±3.84a | 18.74±5.86a | 45.12±19.97a | 74.65±6.21a | 0.85±0.04a |
肥胖MAFLD组 | 129 | 83/46 | 50.3±10.0 | 25.7±0.5a | 20.55±3.05a | 29.19±4.98 | 93.03±22.31a | 88.78±9.47a | 0.93±0.08a |
肥胖非脂肪肝组 | 129 | 83/46 | 51.4±11.1 | 25.3±0.2a | 19.25±3.23a | 27.91±5.43 | 89.00±19.95 | 88.24±4.95a | 0.91±0.04 |
非肥胖MAFLD组 | 129 | 83/46 | 50.0±10.8 | 23.6±1.0 | 18.13±3.58 | 27.54±6.08 | 84.27±22.85 | 84.93±11.47 | 0.91±0.04 |
F(χ2)值 | 0b | 0.411 | 1 860.606 | 232.043 | 91.826 | 135.513 | 77.650 | 62.614 | |
P值 | 1.000 | 0.745 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
组别 | TC(mmol/L) | TG(mmol/L) | HDL-C(mmol/L) | LDL-C(mmol/L) | FPG(mmol/L) | UA(μmol/L) | ALT(U/L) | GGT(U/L) | HbA1c(%) |
非肥胖非脂肪肝组 | 4.36±0.82a | 1.01±0.55a | 1.51±0.33a | 2.41±0.69a | 5.19±1.68 | 324.11±93.29a | 20.46±13.14a | 26.83±42.05a | 5.60±0.75 |
肥胖MAFLD组 | 4.76±0.95 | 2.13±1.47 | 1.15±0.29 | 2.77±0.73 | 6.26±2.13a | 377.13±95.88 | 36.66±22.48 | 49.92±54.22 | 6.15±1.35a |
肥胖非脂肪肝组 | 4.61±0.84 | 1.45±1.06a | 1.23±0.27 | 2.76±0.69 | 5.31±1.55 | 352.25±78.08a | 25.06±17.09a | 30.10±20.91a | 5.72±1.03 |
非肥胖MAFLD组 | 4.78±0.86 | 1.90±1.19 | 1.20±0.29 | 2.83±0.71 | 5.52±1.49 | 383.01±95.80 | 33.04±29.26 | 44.62±39.89 | 5.81±0.88 |
F(χ2)值 | 6.389 | 25.526 | 38.391 | 9.591 | 9.956 | 11.243 | 15.372 | 9.453 | 6.795 |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
性别 | 例数 | 年龄(岁) | BMI(kg/m2) | BF(kg) | BFR(%) | VFA(cm2) | WC(cm) | WHR | TC(mmol/L) |
---|---|---|---|---|---|---|---|---|---|
女 | 46 | 54.0±9.8 | 23.68±0.95 | 20.78±3.38 | 33.64±4.65 | 104.20±22.96 | 80.52±17.83 | 0.90±0.04 | 4.86±0.94 |
男 | 83 | 47.8±10.7 | 23.63±0.99 | 16.70±2.79 | 24.23±3.77 | 73.46±13.77 | 87.33±4.09 | 0.92±0.03 | 4.74±0.81 |
t值 | 3.272 | 0.280 | 7.333 | 12.407 | 8.219 | -2.528 | -1.907 | 0.735 | |
P值 | 0.001 | 0.780 | <0.001 | <0.001 | <0.001 | 0.015 | 0.059 | 0.463 | |
性别 | TG(mmol/L) | HDL-C(mmol/L) | LDL-C(mmol/L) | FPG(mmol/L) | UA(μmol/L) | ALT(U/L) | GGT(U/L) | HbA1c(%) | |
女 | 1.84±1.03 | 1.22±0.26 | 2.93±0.78 | 5.48±1.43 | 321.98±80.55 | 30.27±39.41 | 29.42±25.78 | 5.90±0.83 | |
男 | 1.93±1.28 | 1.19±0.31 | 2.77±0.66 | 5.55±1.54 | 416.83±86.71 | 34.58±21.84 | 53.05±43.78 | 5.76±0.90 | |
t值 | -0.382 | 0.527 | 1.221 | -0.262 | -6.101 | -0.800 | -3.858 | 0.915 | |
P值 | 0.703 | 0.599 | 0.224 | 0.794 | <0.001 | 0.425 | <0.001 | 0.362 |
Table 2 Comparison of body fat composition and metabolic indices between non-obese men and women with MAFLD
性别 | 例数 | 年龄(岁) | BMI(kg/m2) | BF(kg) | BFR(%) | VFA(cm2) | WC(cm) | WHR | TC(mmol/L) |
---|---|---|---|---|---|---|---|---|---|
女 | 46 | 54.0±9.8 | 23.68±0.95 | 20.78±3.38 | 33.64±4.65 | 104.20±22.96 | 80.52±17.83 | 0.90±0.04 | 4.86±0.94 |
男 | 83 | 47.8±10.7 | 23.63±0.99 | 16.70±2.79 | 24.23±3.77 | 73.46±13.77 | 87.33±4.09 | 0.92±0.03 | 4.74±0.81 |
t值 | 3.272 | 0.280 | 7.333 | 12.407 | 8.219 | -2.528 | -1.907 | 0.735 | |
P值 | 0.001 | 0.780 | <0.001 | <0.001 | <0.001 | 0.015 | 0.059 | 0.463 | |
性别 | TG(mmol/L) | HDL-C(mmol/L) | LDL-C(mmol/L) | FPG(mmol/L) | UA(μmol/L) | ALT(U/L) | GGT(U/L) | HbA1c(%) | |
女 | 1.84±1.03 | 1.22±0.26 | 2.93±0.78 | 5.48±1.43 | 321.98±80.55 | 30.27±39.41 | 29.42±25.78 | 5.90±0.83 | |
男 | 1.93±1.28 | 1.19±0.31 | 2.77±0.66 | 5.55±1.54 | 416.83±86.71 | 34.58±21.84 | 53.05±43.78 | 5.76±0.90 | |
t值 | -0.382 | 0.527 | 1.221 | -0.262 | -6.101 | -0.800 | -3.858 | 0.915 | |
P值 | 0.703 | 0.599 | 0.224 | 0.794 | <0.001 | 0.425 | <0.001 | 0.362 |
项目 | r值 | P值 | 项目 | r值 | P值 |
---|---|---|---|---|---|
性别 | 0 | 1.000 | HDL-C | -0.112 | 0.002 |
年龄 | -0.029 | 0.423 | LDL-C | 0.092 | 0.011 |
BFR | 0.099 | 0.007 | UA | 0.114 | 0.002 |
VFA | 0.092 | 0.011 | ALT | 0.125 | 0.001 |
WC | 0.039 | 0.287 | GGT | 0.142 | <0.001 |
WHR | 0.136 | <0.001 | FPG | 0.023 | 0.527 |
TC | 0.095 | 0.009 | HbA1c | 0.029 | 0.434 |
TG | 0.176 | <0.001 | BF | 0.063 | 0.086 |
Table 3 Kendall correlation analysis of body fat and metabolic indices with MAFLD in non-obese people
项目 | r值 | P值 | 项目 | r值 | P值 |
---|---|---|---|---|---|
性别 | 0 | 1.000 | HDL-C | -0.112 | 0.002 |
年龄 | -0.029 | 0.423 | LDL-C | 0.092 | 0.011 |
BFR | 0.099 | 0.007 | UA | 0.114 | 0.002 |
VFA | 0.092 | 0.011 | ALT | 0.125 | 0.001 |
WC | 0.039 | 0.287 | GGT | 0.142 | <0.001 |
WHR | 0.136 | <0.001 | FPG | 0.023 | 0.527 |
TC | 0.095 | 0.009 | HbA1c | 0.029 | 0.434 |
TG | 0.176 | <0.001 | BF | 0.063 | 0.086 |
变量 | β | SE | Waldχ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
BFR | 1.709 | 0.265 | 41.713 | <0.001 | 5.522(3.288,9.274) |
VFA | 2.899 | 0.743 | 15.210 | <0.001 | 18.162(4.230,77.972) |
TG | 0.448 | 0.210 | 4.534 | 0.033 | 1.565(1.036,2.364) |
UA | 0.904 | 0.295 | 9.385 | 0.002 | 2.469(1.385,4.402) |
ALT | 1.261 | 0.408 | 9.565 | 0.002 | 3.529(1.587,7.849) |
Table 4 Multivariate Logistic regression analysis of factors associated with MAFLD in non-obese people
变量 | β | SE | Waldχ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
BFR | 1.709 | 0.265 | 41.713 | <0.001 | 5.522(3.288,9.274) |
VFA | 2.899 | 0.743 | 15.210 | <0.001 | 18.162(4.230,77.972) |
TG | 0.448 | 0.210 | 4.534 | 0.033 | 1.565(1.036,2.364) |
UA | 0.904 | 0.295 | 9.385 | 0.002 | 2.469(1.385,4.402) |
ALT | 1.261 | 0.408 | 9.565 | 0.002 | 3.529(1.587,7.849) |
变量 | AUC(95%CI) | P值 | 灵敏度 | 特异度 | 约登指数 | 最佳临界值 |
---|---|---|---|---|---|---|
BFR | 0.853(0.807,0.898) | <0.001 | 0.789 | 0.770 | 0.559 | 22.30% |
VFA | 0.938(0.906,0.970) | <0.001 | 0.852 | 0.904 | 0.756 | 61.45 cm2 |
TG | 0.807(0.754,0.860) | <0.001 | 0.822 | 0.713 | 0.535 | 1.02 mmol/L |
UA | 0.665(0.599,0.731) | <0.001 | 0.605 | 0.682 | 0.287 | 356.00 μmol/L |
ALT | 0.752(0.692,0.812) | <0.001 | 0.814 | 0.770 | 0.584 | 18.35 U/L |
Table 5 ROC curve of body fat composition and metabolic indices in the diagnosis of MAFLD in non-obese people
变量 | AUC(95%CI) | P值 | 灵敏度 | 特异度 | 约登指数 | 最佳临界值 |
---|---|---|---|---|---|---|
BFR | 0.853(0.807,0.898) | <0.001 | 0.789 | 0.770 | 0.559 | 22.30% |
VFA | 0.938(0.906,0.970) | <0.001 | 0.852 | 0.904 | 0.756 | 61.45 cm2 |
TG | 0.807(0.754,0.860) | <0.001 | 0.822 | 0.713 | 0.535 | 1.02 mmol/L |
UA | 0.665(0.599,0.731) | <0.001 | 0.605 | 0.682 | 0.287 | 356.00 μmol/L |
ALT | 0.752(0.692,0.812) | <0.001 | 0.814 | 0.770 | 0.584 | 18.35 U/L |
变量 | AUC(95%CI) | P值 | 灵敏度 | 特异度 | 约登指数 | 最佳临界值 |
---|---|---|---|---|---|---|
BFR | 0.942(0.910,0.973) | <0.001 | 0.880 | 0.867 | 0.747 | 19.75% |
VFA | 0.974(0.954,0.993) | <0.001 | 0.807 | 0.964 | 0.771 | 59.75 cm2 |
TG | 0.816(0.752,0.879) | <0.001 | 0.807 | 0.711 | 0.518 | 1.02 mmol/L |
UA | 0.688(0.608,0.769) | <0.001 | 0.759 | 0.578 | 0.337 | 360.50 μmol/L |
ALT | 0.754(0.679,0.828) | <0.001 | 0.795 | 0.602 | 0.398 | 20.15 U/L |
Table 6 ROC curve of body fat composition and metabolic indicators for the diagnosis of MAFLD in non-obese males
变量 | AUC(95%CI) | P值 | 灵敏度 | 特异度 | 约登指数 | 最佳临界值 |
---|---|---|---|---|---|---|
BFR | 0.942(0.910,0.973) | <0.001 | 0.880 | 0.867 | 0.747 | 19.75% |
VFA | 0.974(0.954,0.993) | <0.001 | 0.807 | 0.964 | 0.771 | 59.75 cm2 |
TG | 0.816(0.752,0.879) | <0.001 | 0.807 | 0.711 | 0.518 | 1.02 mmol/L |
UA | 0.688(0.608,0.769) | <0.001 | 0.759 | 0.578 | 0.337 | 360.50 μmol/L |
ALT | 0.754(0.679,0.828) | <0.001 | 0.795 | 0.602 | 0.398 | 20.15 U/L |
变量 | AUC(95%CI) | P值 | 灵敏度 | 特异度 | 约登指数 | 最佳临界值 |
---|---|---|---|---|---|---|
BFR | 0.906(0.842,0.969) | <0.001 | 0.844 | 0.860 | 0.705 | 29.75% |
VFA | 0.924(0.861,0.986) | <0.001 | 0.844 | 0.884 | 0.728 | 79.15 cm2 |
TG | 0.789(0.691,0.888) | <0.001 | 0.822 | 0.744 | 0.566 | 1.19 mmol/L |
UA | 0.716(0.607,0.826) | <0.001 | 0.778 | 0.674 | 0.452 | 270.50 μmol/L |
ALT | 0.757(0.655,0.858) | <0.001 | 0.689 | 0.767 | 0.456 | 18.35 U/L |
Table 7 ROC curve analysis of body fat composition and metabolic indices in the diagnosis of MAFLD in non-obese females
变量 | AUC(95%CI) | P值 | 灵敏度 | 特异度 | 约登指数 | 最佳临界值 |
---|---|---|---|---|---|---|
BFR | 0.906(0.842,0.969) | <0.001 | 0.844 | 0.860 | 0.705 | 29.75% |
VFA | 0.924(0.861,0.986) | <0.001 | 0.844 | 0.884 | 0.728 | 79.15 cm2 |
TG | 0.789(0.691,0.888) | <0.001 | 0.822 | 0.744 | 0.566 | 1.19 mmol/L |
UA | 0.716(0.607,0.826) | <0.001 | 0.778 | 0.674 | 0.452 | 270.50 μmol/L |
ALT | 0.757(0.655,0.858) | <0.001 | 0.689 | 0.767 | 0.456 | 18.35 U/L |
[1] |
李婕. 亚洲地区非酒精性脂肪性肝病的流行病学特点[J]. 临床肝胆病杂志,2018,34(12):2515-2519. DOI:10.3969/j.issn.1001-5256.2018.12.006.
|
[2] |
程晓光,李永丽,曾强. 关注健康管理中非酒精性脂肪性肝病的精准评价[J]. 中华健康管理学杂志,2020,14(4):305-307. DOI:10.3760/cma.j.cn115624-20200702-00522.
|
[3] |
范建高. 代谢相关脂肪性肝病现已成为我国第一大慢性肝病[J]. 中华医学信息导报,2021,36(6):6. DOI:10.3760/cma.j.issn.1000-8039.2021.06.106.
|
[4] |
韩琳,谢欢,孙颖,等. 代谢相关脂肪性肝病的诊断与评估现状[J]. 肝脏,2021,26(2):205-210. DOI:10.14000/j.cnki.issn.1008-1704.2021.02.029.
|
[5] |
陈慧婷,周永健. 非肥胖型非酒精性脂肪性肝病的诊治对策[J]. 中华肝脏病杂志,2020(3):203-207.
|
[6] |
|
[7] |
|
[8] |
|
[9] |
邵琮翔,廖献花,钟碧慧. 体质量与非酒精性脂肪性肝病[J]. 肝脏,2019,24(12):1476-1478. DOI:10.14000/j.cnki.issn.1008-1704.2019.12.041.
|
[10] |
赵楠,许杰,李晓晨,等. 腹部脂肪分布对2型糖尿病患者人体成分及胰岛功能的影响[J]. 国际内分泌代谢杂志,2019,39(6):361-367. DOI:10.3760/cma.j.issn.1673-4157.2019.06.001.
|
[11] |
王静,李虎,顾菲,等. 内脏脂肪面积对体质指数正常内脏脂肪面积超标体检人群缺血性心血管病十年发病风险的评估价值研究[J]. 中国全科医学,2019,22(3):279-283. DOI: 10.12114/j.issn.1007-9572.2018.00.076.
|
[12] |
|
[13] |
|
[14] |
杨炯贤,闫洁,彭芸,等. 应用核磁共振测定儿童内脏脂肪验证生物电阻抗技术准确性的研究[J]. 中华健康管理学杂志,2018,12(3):212-215. DOI:10.3760/cma.j.issn.1674-0815.2018.03.005.
|
[15] |
周绍酉,南龙,杨露,等. 生物电阻抗法和定量计算机体层扫描法测量体检人群的内脏脂肪面积的对比研究[J].中华健康管理学杂志,2018,12(5):449-452. DOI:10.3760/cma.j.issn.1674.0815.2018.0.
|
[16] |
胡平方,谢渭芬. 非肥胖型非酒精性脂肪性肝病的特点及其研究进展[J]. 国际消化病杂志,2019,39(6):382-384,393. DOI:10.3969/j.issn.1673G534X.2019.06.002.
|
[17] |
王东旭,林连捷,林艳,等. 体质量指数及血脂与非酒精性脂肪性肝病的关系[J]. 中华实用诊断与治疗杂志,2018,32(1):61-63. DOI:10.13507/j.issn.1674-3474.2018.01.017.
|
[18] |
田甜,胡文炜,李雪,等. 非肥胖人群非酒精性脂肪性肝病代谢特征及危险因素分析[J]. 临床肝胆病杂志,2020,36(6):1310-1313.
|
[19] |
胡江峰,蔡晓波,陆伦根. 脂肪组织在脂肪性肝病发生发展中的作用[J]. 国际消化病杂志,2019,39(3):153-156,161.
|
[20] |
中华医学会内分泌学分会. 非酒精性脂肪性肝病与相关代谢紊乱诊疗共识(第二版)[J].临床肝胆病杂志,2018,34(10):2103-2108. DOI:10.3969/j.issn.1001-5256.2018.10.010.
|
[21] |
|
[22] |
颜红梅. 改善非酒精性脂肪性肝病可以逆转2型糖尿病吗? [J]. 临床肝胆病杂志,2020,36(6):1213-1216. DOI:10.3969/j.issn.1001-5256.2020.06.004.
|
[23] |
|
[24] |
卞华,林寰东,饶圣祥,等. 肝脏脂肪含量与胰岛素抵抗及胰岛β细胞功能的关系[J]. 中华内分泌代谢杂志,2010,26(7):535-540. DOI:10.3760/cma.j.issn.1000-6699.2010.07.003.
|
[25] |
|
[26] |
|
[27] |
|
[28] | |
[29] |
中华医学会内分泌学分会,中国高尿酸血症与痛风诊疗指南(2019)[J].中华内分泌代谢杂志,2020,36(1):1-13. DOI:10.3760/cma.j.issn.1000-6699.2020.01.001
|
[30] |
林仿,任跃忠,褚建平,等. 三酰甘油与高密度脂蛋白胆固醇比值和谷氨酰转移酶对非酒精性脂肪肝的预测价值[J]. 中华全科医学,2017,15(7):1175-1177,1191. DOI:10.16766/j.cnki.issn.1674-4152.2017.07.025.
|
[31] |
中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018更新版)[J]. 中华肝脏病杂志,2018,26(3):195-203. DOI:10.3760/cma.j.issn.1007-3418.2018.03.008.
|
[1] | ZHANG Nawen, HUANG Shaomin, TIAN Limin. Association between Serum Osteocalcin Level and Non-alcoholic Fatty Liver Disease in Adults: a Meta-analysis [J]. Chinese General Practice, 2024, 27(12): 1519-1524. |
[2] | JIN Menglong, QIN Xiaoying, MALIYA Amiti, JIAZINI Nuerbai, LI Jianxin, CAO Jie, LUO Sifu, LIU Cheng, ZHANG Yuchen, GAI Mintao, LI Yanpeng, LU Xiangfeng, FU Zhenyan. Status and Influencing Factors of Dyslipidemia, Hypertension and Diabetes Comorbidities among Kazakhs in Xinjiang [J]. Chinese General Practice, 2024, 27(12): 1438-1444. |
[3] | KANG Jing, ZHANG Ci, ZHANG Zhengyi. Distribution and Influencing Factors of Chronic Comorbidities among Middle-aged Inpatients in General Practice Department of Tertiary General Hospitals [J]. Chinese General Practice, 2024, 27(11): 1310-1315. |
[4] | HE Haiyang, YANG Jialing, LEI Xun. Prevalence and Influencing Factors of Osteoporosis in Postmenopausal Women: a Meta-analysis [J]. Chinese General Practice, 2024, 27(11): 1370-1379. |
[5] | SHANG Jinmeng, DENG Xiaowei. Characteristics and Risk Factors of Preserved Ratio Impaired Spirometry in Physical Examination Population [J]. Chinese General Practice, 2024, 27(11): 1331-1336. |
[6] | YU Xinyan, SU Peng, YUAN Xiaojing, JIANG Qingru, YANG Jianyun, ZHAO Xudong, WANG Yifan, ZHANG Haicheng. A Study on the Factors Influencing the Comprehensive Risk of Cardiovascular Disease in Elderly Patients with Chronic Disease in Primary Care [J]. Chinese General Practice, 2024, 27(10): 1186-1193. |
[7] | DAI Zhenwei, ZHANG Ling, ZHANG Haoran, XIAO Weijun, WANG Hao, HUANG Yiman, JING Shu, CHEN Xu, FU Jiaqi, WU Yijin, GAO Lei, SU Xiaoyou. Influencing Factors of Blood Glucose Monitoring in Middle-aged and Elderly Patients with Type-2 Diabetes Mellitus in Rural Areas [J]. Chinese General Practice, 2024, 27(10): 1194-1200. |
[8] | ZHANG Min, LU Yuan, GAO Song, MA Jia, LIU Yalin, ZHAI Jiayi, YU Dehua. Analysis on the Perceptions Toward Mild Cognitive Impairment and Medical Willingness among Population Aged over 55 Years in Shanghai Based on a Proactive Health Perspective [J]. Chinese General Practice, 2024, 27(10): 1208-1214. |
[9] | XIONG Liufang, ZHOU Xiaozhao, MA Hanying, ZHAO Tiefu. Factors Influencing the Demand for Long-term Family Doctor Contract in Community Health Service Centers [J]. Chinese General Practice, 2024, 27(10): 1238-1244. |
[10] | GAO Chuan, LI Qingyin, KE Dandan, ZHOU Yuyu, ZHANG Yuyang, HE Zhong. The Utilization of Health Checkup Services among People Aged 45 and above in China: a National Cross-sectional Survey Based on CHARLS 2018 [J]. Chinese General Practice, 2024, 27(10): 1179-1185. |
[11] | ZHANG Xing, DONG Jing, GUO Yi, XU Jianwei, BAI Yamin, LIU Min, ZHANG Xiaochang, GUO Xiaolei, MA Jixiang, SUN Xinying. Influencing Factors of Salt-reduction Behavior among Residents: a Mixed Methods Research Based on the PRECEDE Model [J]. Chinese General Practice, 2024, 27(10): 1221-1230. |
[12] | ZHAO Ru, HAN Chen, HUANG Zeyu, WANG Qian, HU Jun, GE Zhijuan, BI Yan, SHEN Shanmei. Correlation of Serum Uric Acid and Serum Uric Acid/Creatinine Ratio Levels with Adverse Pregnancy Outcomes in Late Pregnancy [J]. Chinese General Practice, 2024, 27(09): 1074-1081. |
[13] | WANG Kai, XU Baichao, WANG Zhaoxin, SU Jianjiao. Effects of Combined Motion Intervention on Body Composition, Cardiovascular Risk Factors and Cardiopulmonary Fitness of Obese Female Adolescents [J]. Chinese General Practice, 2024, 27(09): 1109-1117. |
[14] | WANG Xueting, JIANG Yi. Disease Burden of Chronic Obstructive Pulmonary Disease in the BRICS Countries from 1990 to 2019 [J]. Chinese General Practice, 2024, 27(09): 1118-1125. |
[15] | LIANG Keke, GUO Qingge, LI Xiaohuan, MA Jianjun, YANG Hongqi, SHI Xiaoxue, FAN Yongyan, YANG Dawei, GUO Dashuai, DONG Linrui, GU Qi, LI Dongsheng. Predictive Value of Machine Learning Based on Retinal Structural Changes for Early Parkinson's Disease Diagnosis [J]. Chinese General Practice, 2024, 27(09): 1102-1108. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||